|
Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia
|
May 2017
|
Blood
|
acute myeloid leukemia (AML)
|
|
Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes
|
Jun 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.
|
Sep 2013
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
MDS-related mutations in aplastic anemia
|
Oct 2014
|
Blood
|
aplastic anemia
|
|
Clonal hematopoiesis in acquired aplastic anemia
|
Apr 2016
|
Blood
|
aplastic anemia
|
|
Management of the refractory aplastic anemia patient: what are the options?
|
Sep 2013
|
Blood
|
aplastic anemia
|
|
Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life
|
Jan 2014
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
|
Sep 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia
|
Oct 2014
|
Blood
|
aplastic anemia
|
